269983 Prevalence and Factors associated with acute adverse events from over-the-counter Chinese Herbal Medicines: A population-based survey of Hong Kong Chinese adults

Monday, October 29, 2012

Jean Kim, ScD , The School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Vincent Chung, PhD , The School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, NT, Hong Kong
Jamie Rocio Rodas, MPH , Collaborating Centre for Oxford University and CUHK for Disaster and Medical Humanitarian Response, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Terry Wong, BS , The School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, NT, Hong Kong
John Lee, MPH , The School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, NT, Hong Kong
Albert Cheung, MSc , The School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, NT, Hong Kong
Mei-Wah Chan, BS , The School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, NT, Hong Kong
Sian Griffiths, MBChB, OBE , Chinese University of Hong Kong, School of Public Health and Primary Care, Hong Kong, Hong Kong
Background: Over-the-counter proprietary Chinese medicine (pCM) is one of the fastest growing segments of the global pharmaceutical market. Population-based studies of pCM adverse drug reactions, however, have not been undertaken. Methods: A cross-sectional telephone survey was conducted among 1100 Hong Kong Chinese adults in 2011. The past-year prevalence of pCM-related adverse events is examined along with the associated factors. Results: Of respondents, 71.7% reported past-year pCM use with 2.3% reporting pCM-related adverse events (3.2% of pCM users) for which almost one-third required treatment by a health care professional. Among those reporting adverse events, allergic reactions (40.7%), dizziness (18.5%), and gastro-intestinal problems (14.8%) were the most commonly reported acute adverse reactions. Pills/capsules were the form of pCM that caused the highest proportion of adverse events (37%) followed by plasters/dressings (25.9%), creams/ointments (18.5%) and powders (11.1%). PCM users reporting adverse events were more likely to possess lower education levels and have received pCM information from books and mass media sources such as TV and magazines. Pervasive knowledge gaps and low levels of perceived susceptibility to adverse events were shown across pCM users. Package labels were felt to be unclear by 38.7% of users and the main barriers to greater information seeking were the belief that reliable pCM information is unobtainable from Western medical doctors (73%) or pharmacists (67.6%). Conclusions: Previous pCM studies had missed the majority of adverse events. Although governments around the world are moving towards more stringent pCM regulation, lack of access to reliable pCM information and pervasive pCM misconceptions present an ongoing challenge for the safe use of pCM.

Learning Areas:
Implementation of health education strategies, interventions and programs
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy

Learning Objectives:
1. To describe the prevalence of adverse drug reactions from over-the-counter TCM drugs 2. To describe the types of drugs causing these adverse reactions 3. To describe the types of adverse reactions 4. To describe the respondent characteristics that were associated with adverse reactions.

Keywords: Alternative Medicine/Therapies, Drug Safety

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Principal Investigator on an ongoing grant on Traditional Chinese Medicine drug safety in Hong Kong. It is the first population-based study conducted on adverse drug events in the general population. Among my interests are personal perceptions of risk in health behaviors and I have published in areas related to HIV, H5N1 and SARS.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.